Royal Bank of Canada on Track for Record High Close — Data Talk
Royal Bank of Canada (RY) is currently at $121.58, up $0.74 or 0.61%
--Would be new all-time high (Based on available data back to Oct. 16, 1995)
--Currently up 15 of the past 16 days
--Currently up 10 consecutive days; up 7.99% over this period
--Longest winning streak since March 22, 2022, when it rose for 10 straight trading days
--Best 10 day stretch since the 10 days ending May 15, 2024, when it rose 8.33%
--Up 20.22% year-to-date
--Up 36.76% from 52 weeks ago (Sept. 6, 2023), when it closed at $88.90
--Would be a new 52-week closing high
--Up 55.49% from its 52-week closing low of $78.19 on Oct. 27, 2023
--Traded as high as $121.80; new all-time intraday high (Based on available data back to Oct. 16, 1995)
--Up 0.8% at today's intraday high
All data as of 11:41:44 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 04, 2024 11:58 ET (15:58 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks